Try
Madrigal Pharmaceuticals Inc.
MDGLUnited States
61 filed reports · 380 financial concepts · 2 earnings calls · 1 media appearances
Filed reports
61 reports · Jun 2011 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 45 | 3,788 | Jun 2011 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 14 | 3,463 | Dec 2011 to Dec 2025 |
| Annual · 10-K/ASEC EDGAR | 1 | 300 | Dec 2022 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 91 | Sep 2016 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 30, 2026 | 309 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 179 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 19, 2026 | 651 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 4, 2025 | 209 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 5, 2025 | 127 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 1, 2025 | 131 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 26, 2025 | 301 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Oct 31, 2024 | 130 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 7, 2024 | 107 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 7, 2024 | 104 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 28, 2024 | 316 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 6, 2023 | 100 | Open |
Financial data
380 concepts · 7,642 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial370 concepts · 7,553 facts · Dec 2009 to Jul 2026
- Cash and cash equivalents at carrying value84 · Dec 2009 to Jun 2026
- Operating expenses (US GAAP)82 · Dec 2009 to Jun 2026
- Operating income loss82 · Dec 2009 to Jun 2026
- Research and development expense excluding acquired in process cost82 · Dec 2009 to Jun 2026
- Increase decrease in accounts payable trade81 · Dec 2009 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets81 · Dec 2009 to Jun 2026
- Share based compensation81 · Dec 2009 to Jun 2026
- Stockholders equity (US GAAP)80 · Dec 2009 to Jun 2026
- Accounts payable current79 · Dec 2010 to Jun 2026
- Accumulated other comprehensive income loss net of tax79 · Dec 2010 to Jun 2026
- Additional paid in capital common stock79 · Dec 2010 to Jun 2026
- Assets79 · Dec 2010 to Jun 2026
- Assets current79 · Dec 2010 to Jun 2026
- Common stock par or stated value per share79 · Dec 2010 to Jun 2026
- Common stock shares authorized79 · Dec 2010 to Jun 2026
- Common stock shares issued79 · Dec 2010 to Jun 2026
- Common stock shares outstanding79 · Dec 2010 to Jun 2026
- Common stock value79 · Dec 2010 to Jun 2026
- Liabilities79 · Dec 2010 to Jun 2026
- Liabilities and stockholders equity79 · Dec 2010 to Jun 2026
- Liabilities current79 · Dec 2010 to Jun 2026
- Preferred stock par or stated value per share79 · Dec 2010 to Jun 2026
- Preferred stock shares authorized79 · Dec 2010 to Jun 2026
- Preferred stock shares issued79 · Dec 2010 to Jun 2026
Segment9 concepts · 73 facts · Dec 2023 to Jun 2026
- Net income loss12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Research and development - external expense9 · Dec 2023 to Dec 2025
- Research and development - personnel and internal expense9 · Dec 2023 to Dec 2025
- Selling general and administrative expense9 · Dec 2023 to Dec 2025
- Cost of goods and services sold (US GAAP)7 · Dec 2023 to Jun 2026
- Segment reporting other item amount7 · Dec 2023 to Jun 2026
- Interest income expense nonoperating net4 · Jun 2024 to Sep 2025
- Operating costs and expenses4 · Jun 2024 to Sep 2025
Product1 concepts · 16 facts · Dec 2024 to Jun 2026
- Chargebacks, Discounts for Prompt Pay and Other Allowances16 · Dec 2024 to Jun 2026
Segments
89 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 73 facts
- Reportable73 · Dec 2023 to Jun 2026
Product or service3 members · 16 facts
- Chargebacks Discounts For Prompt Pay And Other Allowances8 · Dec 2024 to Jun 2026
- Rebates Customer Fees Credits Co Pay Assistance And Other6 · Dec 2024 to Dec 2025
- Rebates Co Pay Assistance Returns And Other2 · Mar 2026 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary132 claims from 9 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary152 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes27 claims from 1 reports · Dec 2025
- Risk factors158 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · May 2026 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
- FY2026 Q1May 6, 2026
Executive media
1 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- TV interviews1 · Aug 2025
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.